What is it about?
This excerpt discusses the limitations of using the Severity of Alopecia Tool (SALT) score for assessing radiation-induced alopecia (RIA) and advocates for the use of the Common Terminology Criteria for Adverse Events (CTCAE) instead. Advantages of CTCAE for RIA 1) CTCAE is oncology-specific and commonly used in cancer treatment. 2) It offers a standardized grading system for radiation-induced side effects, including alopecia, based on severity and clinical impact. 3) It allows for consistent reporting and comparison across studies.
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
Have a consensus for grading radiation-induced alopecia (hair loss)
Perspectives
We strongly recommend that future studies adopt CTCAE or work toward developing a validated, consensus-driven grading system for radiation-induced alopecia (RIA). This approach will enhance the quality and comparability of research, ultimately guiding clinicians in effectively managing this challenging condition and improving patient outcomes.
Dr. Pouya Saraei
Shiraz University of Medical Sciences
Read the Original
This page is a summary of: In Regard to Torizuka et al, International Journal of Radiation Oncology*Biology*Physics, April 2025, Elsevier,
DOI: 10.1016/j.ijrobp.2024.12.028.
You can read the full text:
Contributors
The following have contributed to this page
